Digitek MDL Plaintiffs Lose Class Certification Bid
The federal judge in multidistrict litigation over the recall of Actavis Inc. and Mylan Inc.'s heart drug Digitek has denied class certification in the MDL's six remaining class actions, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article